Financhill
Sell
36

SRRK Quote, Financials, Valuation and Earnings

Last price:
$32.23
Seasonality move :
-22.61%
Day range:
$30.79 - $32.91
52-week range:
$6.76 - $46.98
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
69.31x
P/B ratio:
8.43x
Volume:
1.1M
Avg. volume:
989.8K
1-year change:
84.91%
Market cap:
$3.1B
Revenue:
--
EPS (TTM):
-$2.46
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $15.4M $18.8M $33.2M -- --
Revenue Growth (YoY) -24.83% 22.16% 76.41% -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $74.1M $108.5M $124.4M $121.9M $184.6M
Selling, General & Admin $28.2M $40.3M $43.1M $49.4M $67.5M
Other Inc / (Exp) $395K -$1.9M -$132K $5.5M $5.8M
Operating Expenses $102.3M $148.7M $167.6M $171.3M $252.1M
Operating Income -$86.9M -$129.9M -$134.4M -$171.3M -$252.1M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$86.5M -$131.8M -$134.5M -$165.8M -$246.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$86.5M -$131.8M -$134.5M -$165.8M -$246.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$86.5M -$131.8M -$134.5M -$165.8M -$246.3M
 
Basic EPS (Cont. Ops) -$2.81 -$3.59 -$2.26 -$1.99 -$2.47
Diluted EPS (Cont. Ops) -$2.81 -$3.59 -$2.26 -$1.99 -$2.47
Weighted Average Basic Share $30.7M $36.7M $59.6M $83.3M $99.8M
Weighted Average Diluted Share $30.7M $36.7M $59.6M $83.3M $99.8M
 
EBITDA -$85.4M -$127.3M -$131.4M -$168.5M -$250.1M
EBIT -$86.9M -$129.9M -$134.4M -$171.3M -$252.1M
 
Revenue (Reported) $15.4M $18.8M $33.2M -- --
Operating Income (Reported) -$86.9M -$129.9M -$134.4M -$171.3M -$252.1M
Operating Income (Adjusted) -$86.9M -$129.9M -$134.4M -$171.3M -$252.1M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $3.4M $4M -- -- --
Revenue Growth (YoY) -54.63% 17.84% -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $21.8M $29.1M $29.6M $35M $50.4M
Selling, General & Admin $7.8M $10.4M $10.8M $13.1M $19M
Other Inc / (Exp) -$467K -$550K $1.2M $1.9M $2.9M
Operating Expenses $29.5M $39.4M $40.4M $48M $69.4M
Operating Income -$26.1M -$35.4M -$40.4M -$48M -$69.4M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$26.6M -$35.9M -$39.3M -$46.1M -$66.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$26.6M -$35.9M -$39.3M -$46.1M -$66.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$26.6M -$35.9M -$39.3M -$46.1M -$66.5M
 
Basic EPS (Cont. Ops) -$0.79 -$0.97 -$0.46 -$0.50 -$0.61
Diluted EPS (Cont. Ops) -$0.79 -$0.97 -$0.46 -$0.50 -$0.61
Weighted Average Basic Share $33.9M $37.2M $79.6M $93M $109.6M
Weighted Average Diluted Share $33.9M $37.2M $79.6M $93M $109.6M
 
EBITDA -$25.8M -$34.6M -$39.7M -$47.4M -$69M
EBIT -$26.1M -$35.4M -$40.4M -$48M -$69.4M
 
Revenue (Reported) $3.4M $4M -- -- --
Operating Income (Reported) -$26.1M -$35.4M -$40.4M -$48M -$69.4M
Operating Income (Adjusted) -$26.1M -$35.4M -$40.4M -$48M -$69.4M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $15.4M $18.8M -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $74.1M $108.5M $124.4M $121.9M $184.6M
Selling, General & Admin $28.2M $40.3M $43.1M $49.4M $67.5M
Other Inc / (Exp) $395K -$1.9M -$132K $5.5M $5.8M
Operating Expenses $102.3M $148.7M $167.6M $171.3M $252.1M
Operating Income -$86.9M -$129.9M -$134.4M -$171.3M -$252.1M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$86.5M -$131.8M -$134.5M -$165.8M -$246.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$86.5M -$131.8M -$134.5M -$165.8M -$246.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$86.5M -$131.8M -$134.5M -$165.8M -$246.3M
 
Basic EPS (Cont. Ops) -$2.81 -$3.59 -$2.28 -$1.99 -$2.46
Diluted EPS (Cont. Ops) -$2.81 -$3.59 -$2.28 -$1.99 -$2.46
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$85.4M -$127.3M -$131.4M -$168.5M -$250.1M
EBIT -$86.9M -$129.9M -$134.4M -$171.3M -$252.1M
 
Revenue (Reported) $15.4M $18.8M -- -- --
Operating Income (Reported) -$86.9M -$129.9M -$134.4M -$171.3M -$252.1M
Operating Income (Adjusted) -$86.9M -$129.9M -$134.4M -$171.3M -$252.1M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $18.8M $33.2M -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $108.5M $124.4M $121.9M $184.6M --
Selling, General & Admin $40.3M $43.1M $49.4M $67.5M --
Other Inc / (Exp) -$1.9M -$132K $5.5M $5.8M --
Operating Expenses $148.7M $167.6M $171.3M $252.1M --
Operating Income -$129.9M -$134.4M -$171.3M -$252.1M --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$131.8M -$134.5M -$165.8M -$246.3M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$131.8M -$134.5M -$165.8M -$246.3M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$131.8M -$134.5M -$165.8M -$246.3M --
 
Basic EPS (Cont. Ops) -$3.59 -$2.28 -$1.99 -$2.46 --
Diluted EPS (Cont. Ops) -$3.59 -$2.28 -$1.99 -$2.46 --
Weighted Average Basic Share $146.8M $238M $333.4M $399.3M --
Weighted Average Diluted Share $146.8M $238M $333.4M $399.3M --
 
EBITDA -$127.3M -$131.4M -$168.5M -$250.1M --
EBIT -$129.9M -$134.4M -$171.3M -$252.1M --
 
Revenue (Reported) $18.8M $33.2M -- -- --
Operating Income (Reported) -$129.9M -$134.4M -$171.3M -$252.1M --
Operating Income (Adjusted) -$129.9M -$134.4M -$171.3M -$252.1M --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $160.4M $212.8M $103.3M $101.9M $177.9M
Short Term Investments $180.7M $40.2M $212.1M $178.1M $259.4M
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- $9.9M $7.2M $11.7M
Other Current Assets $3.4M $12.3M -- -- --
Total Current Assets $344.4M $265.3M $328M $288.2M $451.2M
 
Property Plant And Equipment $40.4M $35M $25.9M $16M $18.4M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- $4.1M $2.4M
Other Long-Term Assets $3.5M $4.1M $4.2M $2.4M $2.4M
Total Assets $388.3M $304.4M $358.2M $311M $474.9M
 
Accounts Payable $3.4M $4.4M $4M $3.5M $10.1M
Accrued Expenses $13.7M $17.5M $24.3M $20.4M $31.1M
Current Portion Of Long-Term Debt -- $1.6M -- $1.3M --
Current Portion Of Capital Lease Obligations $5.4M $7.4M $7.9M $7.4M $5.8M
Other Current Liabilities $15K $230K $222K $85K --
Total Current Liabilities $42.6M $64.3M $36.4M $32.7M $46.9M
 
Long-Term Debt $24.7M $48.4M $49.7M $48.7M $50.1M
Capital Leases -- -- -- -- --
Total Liabilities $127.5M $132.4M $97.9M $85.8M $106.3M
 
Common Stock $34K $35K $52K $76K $94K
Other Common Equity Adj -$2K -$35K -$884K $92K $160K
Common Equity $260.8M $172.1M $260.2M $225.2M $368.6M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $260.8M $172.1M $260.2M $225.2M $368.6M
 
Total Liabilities and Equity $388.3M $304.4M $358.2M $311M $474.9M
Cash and Short Terms $341M $253M $315.4M $279.9M $437.3M
Total Debt $24.7M $50M $49.7M -- --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $160.4M $212.8M $103.3M $101.9M $177.9M
Short Term Investments $180.7M $40.2M $212.1M $178.1M $259.4M
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- $9.9M $7.2M $11.7M
Other Current Assets $3.4M $12.3M -- -- --
Total Current Assets $344.4M $265.3M $328M $288.2M $451.2M
 
Property Plant And Equipment $40.4M $35M $25.9M $16M $18.4M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- $4.1M $2.4M
Other Long-Term Assets $3.5M $4.1M $4.2M $2.4M $2.4M
Total Assets $388.3M $304.4M $358.2M $311M $474.9M
 
Accounts Payable $3.4M $4.4M $4M $3.5M $10.1M
Accrued Expenses $13.7M $17.5M $24.3M $20.4M $31.1M
Current Portion Of Long-Term Debt -- $1.6M -- $1.3M --
Current Portion Of Capital Lease Obligations $5.4M $7.4M $7.9M $7.4M $5.8M
Other Current Liabilities $15K $230K $222K $85K --
Total Current Liabilities $42.6M $64.3M $36.4M $32.7M $46.9M
 
Long-Term Debt $24.7M $48.4M $49.7M $48.7M $50.1M
Capital Leases -- -- -- -- --
Total Liabilities $127.5M $132.4M $97.9M $85.8M $106.3M
 
Common Stock $34K $35K $52K $76K $94K
Other Common Equity Adj -$2K -$35K -$884K $92K $160K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $260.8M $172.1M $260.2M $225.2M $368.6M
 
Total Liabilities and Equity $388.3M $304.4M $358.2M $311M $474.9M
Cash and Short Terms $341M $253M $315.4M $279.9M $437.3M
Total Debt $24.7M $50M -- -- --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$86.5M -$131.8M -$134.5M -$165.8M -$246.3M
Depreciation & Amoritzation $1.5M $2.6M $3M $2.8M $1.9M
Stock-Based Compensation $11.2M $23.1M $27.7M $27.1M $36.6M
Change in Accounts Receivable $25M -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$60.3M -$126.8M -$132.7M -$145.2M -$200.9M
 
Capital Expenditures $4.1M $5.2M $1.1M -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$63.5M $134.3M -$171.7M $41.1M -$76.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $24.6M $25M -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$19K -$20K -$975K $3K -$125K
Cash From Financing $247.8M $45M $194.8M $102.6M $353M
 
Beginning Cash (CF) $38.8M $162.9M $215.3M $105.8M $104.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $124.1M $52.5M -$109.6M -$1.5M $76M
Ending Cash (CF) $162.9M $215.3M $105.8M $104.3M $180.3M
 
Levered Free Cash Flow -$64.4M -$132M -$133.8M -$145.3M -$201M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$26.6M -$35.9M -$39.3M -$46.1M -$66.5M
Depreciation & Amoritzation $319K $727K $749K $672K $395K
Stock-Based Compensation $2.5M $6.1M $6.2M $7M $9.5M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$19.7M -$32.5M -$28.9M -$37.3M -$49.5M
 
Capital Expenditures $2M $542K -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$122.6M $29.5M $77K -$25.1M -$195.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$4K -$1K -- -- --
Cash From Financing $246.5M $39.7M -$970K $96.5M $346.4M
 
Beginning Cash (CF) $58.7M $178.6M $135.6M $70.2M $78.8M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $104.1M $36.7M -$29.8M $34.1M $101.5M
Ending Cash (CF) $162.9M $215.3M $105.8M $104.3M $180.3M
 
Levered Free Cash Flow -$21.7M -$33M -$29M -$37.3M -$49.5M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$86.5M -$131.8M -$134.5M -$165.8M -$246.3M
Depreciation & Amoritzation $1.5M $2.6M $3M $2.8M $1.9M
Stock-Based Compensation $11.2M $23.1M $27.7M $27.1M $36.6M
Change in Accounts Receivable $25M -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$60.3M -$126.8M -$132.7M -$145.2M -$200.9M
 
Capital Expenditures $4.1M $5.2M -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$63.5M $134.3M -$171.7M $41.1M -$76.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$19K -$20K -- $3K --
Cash From Financing $247.8M $45M $194.8M $102.6M $353M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $124.1M $52.5M -$109.6M -$1.5M $76M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$64.4M -$132M -$133.8M -$145.3M -$201M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders -$131.8M -$134.5M -$165.8M -$246.3M --
Depreciation & Amoritzation $2.6M $3M $2.8M $1.9M --
Stock-Based Compensation $23.1M $27.7M $27.1M $36.6M --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$126.8M -$132.7M -$145.2M -$200.9M --
 
Capital Expenditures $5.2M $443K -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing $134.3M -$171.7M $41.1M -$76.1M --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$20K -- $3K -$125K --
Cash From Financing $45M $194.8M $102.6M $353M --
 
Beginning Cash (CF) $712.5M $761.8M $440.4M $373.2M --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $52.5M -$109.6M -$1.5M $76M --
Ending Cash (CF) $765M $652.2M $438.9M $449.2M --
 
Levered Free Cash Flow -$132M -$133.8M -$145.3M -$201M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Is Raymond James Stock a Buy, Sell or Hold?
Is Raymond James Stock a Buy, Sell or Hold?

Raymond James Financial (NYSE:RJF) is one of America’s large financial…

Is JHX Stock a Buy Sell or Hold?
Is JHX Stock a Buy Sell or Hold?

James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
69
AJINY alert for Apr 1

Ajinomoto [AJINY] is down 2.15% over the past day.

Sell
40
RGC alert for Mar 31

Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.

Buy
62
AGX alert for Apr 1

Argan [AGX] is down 4.98% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock